Literature DB >> 24258351

Activation of postsynaptic 5-HT1A receptors improve stress adaptation.

Jiansong Zhou1, Xia Cao, Adam C Mar, Yu-Qiang Ding, Xiaoping Wang, Qi Li, Lingjiang Li.   

Abstract

RATIONALE: Serotonin-1A (5-HT1A) receptors modulate the stress response and have been implicated in the etiology and treatment of depression and anxiety disorders. A reduction in postsynaptic 5-HT1A receptor function in limbic areas has consistently been observed following exposure to chronic stress.
OBJECTIVES: To investigate the hypothesis that increased activation of 5-HT1A receptors in rats having reduced 5-HT function may improve stress adaptation and the behavioral sequelae commonly associated with chronic stress.
METHODS: One hundred forty-four Sprague-Dawley rats received injections of para-chlorophenylalanine to partially deplete 5-HT then were given daily systemic pretreatment with the 5-HT1A receptor agonist, 8-hydroxy-2- (di-n-propylamino) tetralin (8-OH-DPAT), the antagonist, WAY 100635, or vehicle prior to either restraint stress (6 h/day for 10 daily sessions) or control conditions. Anxiety- and depressive-like behaviors were then assessed using the open field and sucrose preference tests. Protein level of hippocampal glucocorticoid receptors (GR) and mineralocorticoid receptors was detected by immunohistochemistry and brain-derived neurotrophic factor (BDNF) was determined by in situ hybridization.
RESULTS: 8-OH-DPAT pretreatment prior to stress exposure attenuated later stress-induced anxiety- and depression-like behaviors and increased GR and BDNF mRNA expression in the hippocampus relative to vehicle- and WAY 100635-pretreated, stressed animals.
CONCLUSION: The stress-related impairments associated with 5-HT deficiency can be improved by 8-OH-DPAT pretreatment prior to stress exposure and are associated with an augmentation of GR-like immunoreactivity and BDNF mRNA expression in the hippocampus. It suggested that selective activation of 5-HT1A receptors may be a potential treatment strategy for stress-related disorders such as anxiety and depression.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24258351     DOI: 10.1007/s00213-013-3350-z

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  48 in total

1.  Anterograde transport of endogenous brain-derived neurotrophic factor in hippocampal mossy fibers.

Authors:  M A Smith; L X Zhang; W E Lyons; L A Mamounas
Journal:  Neuroreport       Date:  1997-05-27       Impact factor: 1.837

2.  Post-stress facilitation of serotonergic, but not noradrenergic, neurotransmission in the dorsal hippocampus prevents learned helplessness development in rats.

Authors:  Sâmia Regiane Lourenço Joca; Tatiane Zanelati; Francisco Silveira Guimarães
Journal:  Brain Res       Date:  2006-04-19       Impact factor: 3.252

3.  Pre- or postsynaptic activity of 5-HT1A compounds in mice depends on the anxiety paradigm.

Authors:  C López-Rubalcava
Journal:  Pharmacol Biochem Behav       Date:  1996-08       Impact factor: 3.533

4.  Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult.

Authors:  Cornelius Gross; Xiaoxi Zhuang; Kimberly Stark; Sylvie Ramboz; Ronald Oosting; Lynn Kirby; Luca Santarelli; Sheryl Beck; René Hen
Journal:  Nature       Date:  2002-03-28       Impact factor: 49.962

Review 5.  The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity.

Authors:  Eero Castrén; Tomi Rantamäki
Journal:  Dev Neurobiol       Date:  2010-04       Impact factor: 3.964

Review 6.  Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders.

Authors:  R M Sapolsky
Journal:  Arch Gen Psychiatry       Date:  2000-10

7.  Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions.

Authors:  Stephanie Ridder; Sabine Chourbaji; Rainer Hellweg; Alexandre Urani; Christiane Zacher; Wolfgang Schmid; Mathias Zink; Heide Hörtnagl; Herta Flor; Fritz A Henn; Günther Schütz; Peter Gass
Journal:  J Neurosci       Date:  2005-06-29       Impact factor: 6.167

8.  Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus.

Authors:  M A Smith; S Makino; R Kvetnansky; R M Post
Journal:  J Neurosci       Date:  1995-03       Impact factor: 6.167

9.  Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding.

Authors:  M Pompeiano; J M Palacios; G Mengod
Journal:  J Neurosci       Date:  1992-02       Impact factor: 6.167

Review 10.  International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).

Authors:  D Hoyer; D E Clarke; J R Fozard; P R Hartig; G R Martin; E J Mylecharane; P R Saxena; P P Humphrey
Journal:  Pharmacol Rev       Date:  1994-06       Impact factor: 25.468

View more
  11 in total

Review 1.  Biomarkers of epileptogenesis: psychiatric comorbidities (?).

Authors:  Andres M Kanner; Andrey Mazarati; Matthias Koepp
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

Review 2.  Prevalence, Risk Factors, Pathophysiology, Potential Biomarkers and Management of Feline Idiopathic Cystitis: An Update Review.

Authors:  Chengxi He; Kai Fan; Zhihui Hao; Na Tang; Gebin Li; Shuaiyu Wang
Journal:  Front Vet Sci       Date:  2022-06-21

Review 3.  The endocannabinoid system as a target for novel anxiolytic drugs.

Authors:  Sachin Patel; Mathew N Hill; Joseph F Cheer; Carsten T Wotjak; Andrew Holmes
Journal:  Neurosci Biobehav Rev       Date:  2017-05       Impact factor: 8.989

Review 4.  [Depression and epilepsy : Two clinical pictures with common causes?].

Authors:  M Borgmann; M Holtkamp; M Adli; J Behr
Journal:  Nervenarzt       Date:  2016-07       Impact factor: 1.214

Review 5.  Common Mechanisms Underlying Epileptogenesis and the Comorbidities of Epilepsy.

Authors:  Andrey Mazarati; Raman Sankar
Journal:  Cold Spring Harb Perspect Med       Date:  2016-07-01       Impact factor: 6.915

Review 6.  Cannabidiol as a Potential Treatment for Anxiety Disorders.

Authors:  Esther M Blessing; Maria M Steenkamp; Jorge Manzanares; Charles R Marmar
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

Review 7.  The role of serotonin neurotransmission in rapid antidepressant actions.

Authors:  A L Pehrson; D Roberts; A Khawaja; R McNair
Journal:  Psychopharmacology (Berl)       Date:  2022-03-25       Impact factor: 4.530

8.  Circuits Regulating Pleasure and Happiness-Mechanisms of Depression.

Authors:  Anton J M Loonen; Svetlana A Ivanova
Journal:  Front Hum Neurosci       Date:  2016-11-10       Impact factor: 3.169

Review 9.  Serotonin and brain function: a tale of two receptors.

Authors:  R L Carhart-Harris; D J Nutt
Journal:  J Psychopharmacol       Date:  2017-08-31       Impact factor: 4.153

10.  Beneficial effect of fluoxetine treatment aganist psychological stress is mediated by increasing BDNF expression in selected brain areas.

Authors:  Gongying Li; Ping Jing; Zhidong Liu; Zhiruo Li; Hongxia Ma; Wenzhen Tu; Wei Zhang; Chuanjun Zhuo
Journal:  Oncotarget       Date:  2017-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.